SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 57.07 |
| Enterprise Value ($M) | 52.46 |
| Book Value ($M) | 83.42 |
| Book Value / Share | 3.36 |
| Price / Book | 0.68 |
| NCAV ($M) | 50.48 |
| NCAV / Share | 2.03 |
| Price / NCAV | 1.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.41 |
| Current Ratio | 14.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 56.13 |
| Assets | 89.07 |
| Liabilities | 5.65 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -43.00 |
| Net Income | -40.33 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -39.53 |
| Cash from Investing | -45.29 |
| Cash from Financing | 33.02 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Biotechnology Value Fund L P | 17.90 | 85.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 40,354 | 32,685 | 123.46 | |
| 35,411 | 24,785 | 142.87 | |
| 51,695 | 37,089 | 139.38 | |
| 145,726 | 454,501 | 32.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DYAI – Dyadic International, Inc. | EDSA – Edesa Biotech, Inc. |
| EFTR – eFFECTOR Therapeutics, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io